Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 12 - 03 entities : Eli lilly and company save search
AbCellera-Discovered Bamlanivimab Together with Etesevimab Authorized as the First and Only Antibody Therapy for Emergency Use in COVID-19 Patients Under the Age of 12
Published: 2021-12-03 (Crawled : 22:00) - biospace.com/
ABCL | $3.985 -0.62% -0.63% 1.6M
|
|
| O: 3.41%
H: 0.0%
C: 0.0%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 2.15%
H: 0.0%
C: 0.0%
covid therapy authorized antibody merge
Lilly's bamlanivimab with etesevimab authorized as the first and only neutralizing antibody therapy for emergency use in COVID-19 patients under the age of 12
Published: 2021-12-03 (Crawled : 20:00) - prnewswire.com
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
covid therapy authorized antibody merge
BioSpace Movers & Shakers, Dec. 3
Published: 2021-12-03 (Crawled : 17:00) - biospace.com/
DERM | $3.59 1.41% 1.39% 75K
|
|
| O: 0.04%
H: 3.37%
C: -0.04%
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: 3.91%
H: 0.0%
C: 0.0%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 2.15%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
ORIC | $8.75 0.34% 0.34% 270K
|
Health Technology
|
| O: 1.53%
H: 2.58%
C: 1.29%
IART | $29.38 1.38% 1.36% 1M
|
Health Technology
|
| O: 0.2%
H: 0.34%
C: -1.71%
PODD | $167.18 1.68% 1.65% 550K
|
Health Technology
|
| O: 0.81%
H: 1.09%
C: -9.12%
space spac
Innovent and Lilly Announce Successful Expansion of Sintilimab in China National Reimbursement Drug List to Include Three Additional First-Line Indications
Published: 2021-12-03 (Crawled : 09:00) - biospace.com/
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 2.15%
H: 0.0%
C: 0.0%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 1.18%
H: 0.0%
C: 0.0%
expansion drug china
HUTCHMED Announces Agreement with NHSA for Continued Inclusion of ELUNATE® and Addition of SULANDA® in the National Reimbursement Drug List in China
Published: 2021-12-03 (Crawled : 06:00) - globenewswire.com
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 2.15%
H: 0.0%
C: 0.0%
HCM | $18.2 7.44% 6.92% 120K
|
Health Technology
|
| O: -5.2%
H: 0.0%
C: 0.0%
BGNE | $139.22 6.32% 5.95% 200K
|
Health Technology
|
| O: -0.98%
H: 0.0%
C: 0.0%
drug china
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.